- Home
- LTC vs VERA Comparison
LTC vs VERA Comparison
Compare LTC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- VERA
- Stock Information
- Founded
- LTC 1992
- VERA 2016
- Country
- LTC United States
- VERA United States
- Employees
- LTC N/A
- VERA N/A
- Industry
- LTC Real Estate Investment Trusts
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- LTC Real Estate
- VERA Health Care
- Exchange
- LTC Nasdaq
- VERA Nasdaq
- Market Cap
- LTC 1.7B
- VERA 1.7B
- IPO Year
- LTC 1992
- VERA 2021
- Fundamental
- Price
- LTC $35.21
- VERA $31.16
- Analyst Decision
- LTC Hold
- VERA Buy
- Analyst Count
- LTC 5
- VERA 9
- Target Price
- LTC $38.80
- VERA $62.25
- AVG Volume (30 Days)
- LTC 408.4K
- VERA 1.3M
- Earning Date
- LTC 11-04-2025
- VERA 11-06-2025
- Dividend Yield
- LTC 6.47%
- VERA N/A
- EPS Growth
- LTC N/A
- VERA N/A
- EPS
- LTC 1.81
- VERA N/A
- Revenue
- LTC $213,197,000.00
- VERA N/A
- Revenue This Year
- LTC N/A
- VERA N/A
- Revenue Next Year
- LTC $6.87
- VERA N/A
- P/E Ratio
- LTC $19.49
- VERA N/A
- Revenue Growth
- LTC 8.74
- VERA N/A
- 52 Week Low
- LTC $31.70
- VERA $18.53
- 52 Week High
- LTC $39.89
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- LTC 47.07
- VERA 70.08
- Support Level
- LTC $33.77
- VERA $29.58
- Resistance Level
- LTC $37.25
- VERA $31.97
- Average True Range (ATR)
- LTC 0.65
- VERA 1.27
- MACD
- LTC -0.07
- VERA -0.10
- Stochastic Oscillator
- LTC 38.22
- VERA 76.53
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.